Grey Matters Health rebrands around a new brain health vision
Grey Matters Health has rebranded to focus on building a dedicated brain PET scan diagnostic network in the U.S. The company aims to open its first clinic in Florida by September, shifting from its previous focus on drug repurposing. This strategic pivot comes in response to increasing demand for brain diagnostics, particularly for Alzheimer's treatments.
- ▪Grey Matters Health is transitioning from drug repurposing to neuroimaging.
- ▪The first clinic will be located in Davie, Florida, and is set to open in September.
- ▪The new PET scanner technology offers a more patient-friendly experience and reduces radiation exposure.
Opening excerpt (first ~120 words) tap to expand
Grey Matters Health rebrands around a new brain health vision Grey Matters Health rebrands around a new brain health vision Proactive uses images sourced from Shutterstock Proactive Wed, May 20, 2026 at 9:00 AM PDT 5 min read AGNPD +0.04% AGW0.F -3.46% After five years building and advancing a pharmaceutical pipeline that proved difficult to fund, Christopher Moreau decided it was time to find a new cash flow focused path in healthcare that could provide explosive returns for investors. The result is Grey Matters Health (CSE:GREY, OTCQB:AGNPD, FRA:AGW0) — a rebranded, refocused company with a singular mission: to build the United States' first dedicated brain PET scan diagnostic network, starting with a flagship clinic in Florida set to open in September.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Yahoo Finance.